Sucampo, Takeda obtain expanded approval for Amitiza

04/23/2013 | CNBC

The FDA has granted Sucampo Pharmaceuticals and Takeda Pharmaceuticals expanded approval for their Amitiza drug to treat constipation from opioids used for chronic pain. Forty percent or more of patients who use opioids for chronic pain not associated with cancer experience constipation, the companies said.

View Full Article in:

CNBC

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA